Sangamo Therapeutics (SGMOQ) EBIT (2010 - 2025)
Sangamo Therapeutics (SGMOQ) posted quarterly EBIT of -$38.2 million for Q4 2025, down 46.99% year-over-year from -$72.1 million in Q4 2024, and down 7.45% quarter-over-quarter from -$35.6 million in Q3 2025.
Sangamo Therapeutics (SGMOQ) EBIT (2010 - 2025) Analysis & Trends
Sangamo Therapeutics' EBIT history runs 16 years deep, the most recent figure standing at -$38.2 million for Q4 2025.
- In Q4 2025, EBIT fell 46.99% year-over-year to -$38.2 million; the TTM figure through Dec 2025 stood at -$121.2 million (down 16.61% YoY), while the FY2025 annual figure was -$121.2 million, down 16.61% from the prior year.
- EBIT for Q4 2025 stood at -$38.2 million, down from -$35.6 million in the prior quarter.
- The five-year high for EBIT was $18.0 million in Q1 2023, with the low at -$123.6 million in Q2 2023.
- The 5-year median for EBIT is -$45.5 million (2022), against an average of -$44.2 million.
- The sharpest annual moves came in 2021 and 2023: EBIT sank 1208.73% in 2021, then surged 139.84% in 2023.
- Sangamo Therapeutics' EBIT stood at -$39.9 million in 2021, then plunged by 38.83% to -$55.4 million in 2022, then declined by 12.04% to -$62.1 million in 2023, then surged by 58.12% to -$26.0 million in 2024, then plunged by 46.99% to -$38.2 million in 2025.
- Business Quant data shows SGMOQ's EBIT at -$38.2 million in Q4 2025, -$35.6 million in Q3 2025, and -$17.9 million in Q2 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -38.20 Mn |
| Sep 30, 2025 | -35.55 Mn |
| Jun 30, 2025 | -17.86 Mn |
| Mar 31, 2025 | -29.63 Mn |
| Dec 31, 2024 | -25.99 Mn |
| Sep 30, 2024 | 10.63 Mn |
| Jun 30, 2024 | -37.08 Mn |
| Mar 31, 2024 | -51.53 Mn |
| Dec 31, 2023 | -62.06 Mn |
| Sep 30, 2023 | -106.41 Mn |
| Jun 30, 2023 | -123.57 Mn |
| Mar 31, 2023 | 18.03 Mn |
| Dec 31, 2022 | -55.39 Mn |
| Sep 30, 2022 | -54.89 Mn |
| Jun 30, 2022 | -45.73 Mn |
| Mar 31, 2022 | -45.26 Mn |
| Dec 31, 2021 | -39.90 Mn |
| Sep 30, 2021 | -48.44 Mn |
| Jun 30, 2021 | -48.70 Mn |
| Mar 31, 2021 | -46.30 Mn |